ARTICLES BY MATHINI ILANCHERAN
-
U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact2/18/2026
Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.
-
Global Implications Of Zero Tariffs On Indian Pharma Exports To China11/5/2025
Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development10/21/2025
Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.